Clinical Trials Directory

Trials / Completed

CompletedNCT00764140

Tumor Growth Factors in Hepatocellular Carcinoma

Insulin-like Growth Factors (IGF) Axis (IGFs, Its Binding Proteins,Receptors), Transforming Growth Factor Alpha and Beta 1 and Epidermal Growth Factor in the Urine and Serum of Patients With Hepatocellular Carcinoma.

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Malignant cells frequently produce many tumor growth factors to autocidal or endocrinal proliferate growth, metastasis,or angiogenesis about tumor cells. By studying tumor growth factors in hepatocellular carcinoma, one may know the tumor behavior, its relationship with clinical manifestation or invasion, and could be used as diagnostic or prognostic tools.This study aims to study the relationship between tumor growth factors in HCC ant its clinical relevance.

Detailed description

The clinical relevance of patients will be evaluated by the concentrations of tumor growth factors.

Conditions

Interventions

TypeNameDescription
BIOLOGICALtumor growth factor concentrationspot urine or blood collection will be used to measure specific tumor growth factor

Timeline

Start date
2007-01-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2008-10-01
Last updated
2013-04-18

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00764140. Inclusion in this directory is not an endorsement.